BioNumerik Pharmaceuticals, Inc. Overview

State:Texas
Country:United States
Industry:Biotechnology and Drugs
Description:
BioNumerik Pharmaceuticals is focused on the discovery, development and commercialization of novel drugs for the treatment of patients with cancer and the side effects often associated with many therapies. The company, utilizing mechanism-based drug discovery technologies, employs a variety of multi-disciplinary sciences, including chemistry, biology and quantum physics to identify, simulate and better understand the mechanisms by which drugs and their targets function. BioNumerik has two late-stage drugs in development. Lead candidate Tavocept, which has FDA fast-track status, may prevent nerve and kidney damage... (More)

Get Trial Access to OneSource

Company profiles, executive contacts, industry research, and news for sales, marketing and research professionals.

Business Information

Executive Profiles

Company Lists

Disclaimer: While the OneSource Subscription Service maintains the freshest, most accurate data possible, this free site is refreshed on a periodic basis and may occasionally contain information that is not current. If you would like to alert us to a change, please email us, and we will take steps to make sure your update is included as soon as possible